Výsledky vyhledávání

Akademický článek

A Rare Case of Bilateral Pectoralis Major Muscle Defect and Abnormal Muscle

Autor: Mayuko Yamamoto, Tomonari Kunihisa, Motoi Baba, Sachiko Mizumoto, Yuji Yamashita, Mayuko Miki, Sachiko Inubushi, Aoi Okamoto, Ryuhei Fujimoto, Hirokazu Tanino

Publikováno v: Case Reports in Oncology, Vol 15, Iss 1, Pp 351-355 (2022)

A 56-year-old female patient with left breast cancer presented at our hospital. Preoperative CT scan showed an isolated bilateral pectoralis major muscle defect and abnormal muscle originating from the entire sternum and inserting in the lower ribs a

Externí odkaz: https://doaj.org/article/3e241bdb627a4816a933cec9da23191c

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Methionine Restriction Increases Exosome Production and Secretion in Breast Cancer Cells.

Autor: SACHIKO INUBUSHI, TOMONARI KUNIHISA, SACHIKO MIZUMOTO, SHOTARO INOUE, MAYUKO MIKI, ATSUSHI SUETSUGU, HIROKAZU TANINO, HOFFMAN, ROBERT M.

Publikováno v: Cancer Genomics & Proteomics (1109-6535); Sep/Oct2023, Vol. 20 Issue 5, p412-416, 5p

Zobrazit plný text záznamu

Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel

Autor: Mayuko Miki, Koichi Hirokaga, Misao Soyama, Takuma Onoe, Kazuki Hashimoto, Koji Matsumoto, Minori Arase, Hideki Sakai, Meiko Nishimura, Shintaro Takao, Kaori Tane, Sayuri Watanabe

Publikováno v: Anticancer Research. 39:4379-4383

Background/aim Dose-dense doxorubicin and cyclophosphamide (ddAC) followed by dose-dense paclitaxel (ddP) (ddAC-P) has improved disease-free survival of patients with breast cancer. The aim of this study was to evaluate the safety and relative dose i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::556ea63a0fc6f75d9a6307d77d53e5d3
https://doi.org/10.21873/anticanres.13607

Zobrazit plný text záznamu

Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery

Autor: Ryohei Sasaki, Koichi Hirokaga, Toshinori Soejima, Shintaro Takao, Yoko Matsumoto, Mayuko Miki, Hiroki Kawaguchi, Yosuke Ota, Kayoko Tsujino

Publikováno v: Japanese Journal of Clinical Oncology. 49:545-553

Objective To compare patient preferences and acute adverse events of hypofractionated (HF) and conventionally fractionated (CF) whole-breast irradiation (WBI) after breast-conserving surgery in our institution. Methods We conducted a patient preferen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb6ced5a538059479f72adb65458c48
https://doi.org/10.1093/jjco/hyz003

Zobrazit plný text záznamu

Investigation of a Novel S-1 Administration Schedule for Treating Metastatic and Recurrent Breast Cancer (KBCOG13)

Autor: Masaru Miyashita, Michiko Imamura, Kazuhiko Yamagami, Mayuko Miki, Toshitaka Okuno, Shintaro Takao, Hirofumi Suwa, Muneharu Konishi, Yasuo Miyoshi, Yasushi Shigeoka, Koichi Hirokaga, Keiko Murase, Hirokazu Tanino, Ayako Yanai

Publikováno v: Anticancer research. 41(6)

Background/aim S-1, a 5-fluorouracil(5-FU) oral anti-cancer drug, has been traditionally used with a schedule of 4-week oral administration followed by 2-week rest for breast cancer treatment. We, herein, aimed to investigate the clinical efficacy an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::152b6e30c000c823866e19182272b04a
https://pubmed.ncbi.nlm.nih.gov/34083305

Zobrazit plný text záznamu

Investigation of the use of a novel S-1 administration method for treating metastatic and recurrent breast cancer

Autor: Muneharu Konishi, Y Shigeoka, Hirofumi Suwa, Yasuo Miyoshi, Shintaro Takao, Kazuhiko Yamagami, Keiko Murase, Ayako Yanai, Mayuko Miki, Masayuki Imamura, Masaru Miyashita, Toshitaka Okuno, K. Hirokaga, Kohei Akazawa

Publikováno v: Annals of Oncology. 30:ix17-ix18

Background When considering treatment for metastatic and recurrent breast cancer, it is necessary to select drugs with emphasis on side effects and QOL. In Japan, oral 5-FU drugs have often been used for initial treatment. In the conventional schedul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b9a67c6e7916997e54afa292b146d214
https://doi.org/10.1093/annonc/mdz418.010

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání